We assessed 141 stage IV metastatic melanoma patients with age, gender, organ site, and ac-DNMT1/DNMT1/TIP60/USP7 H-scores in a regression model (Table 1, Table 2, Table 3 and Table 4). This evidence concerns the gene KAT5 and metastatic melanoma.